Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,787 | -37,997 | -32,135 | 221,816 | 242,641 |
| Depreciation Amortization | -4,895 | -3,368 | -1,508 | 2,568 | 3,449 |
| Accounts receivable | -5,628 | -2,936 | -1,883 | 1,479 | 2,169 |
| Other Working Capital | -35,236 | -46,196 | -24,080 | 21,917 | 11,987 |
| Other Operating Activity | 28,333 | 15,598 | 8,009 | -274,560 | -282,220 |
| Operating Cash Flow | $-58,213 | $-74,899 | $-51,597 | $-26,780 | $-21,974 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -111 | -98 | N/A | -568 | -865 |
| Purchase Of Investment | -181,181 | -146,287 | -55,629 | -552,737 | -401,069 |
| Sale Of Investment | 403,490 | 308,809 | 121,181 | 451,921 | 355,485 |
| Other Investing Activity | -6,155 | -6,155 | -6,229 | 363,233 | 363,233 |
| Investing Cash Flow | $216,043 | $156,269 | $59,323 | $261,849 | $316,784 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -110,019 | N/A | N/A | -268,408 | -261,562 |
| Common Stock Issued | 74 | 21 | 15 | 1,684 | 433 |
| Other Financing Activity | -351 | -318 | -269 | -592 | -515 |
| Financing Cash Flow | $-110,296 | $-297 | $-254 | $-267,316 | $-261,644 |
| Exchange Rate Effect | 262 | 428 | -308 | -6,302 | -7,399 |
| Beginning Cash Position | 55,860 | 55,860 | 55,860 | 94,409 | 94,409 |
| End Cash Position | 103,656 | 137,361 | 63,024 | 55,860 | 120,176 |
| Net Cash Flow | $47,796 | $81,501 | $7,164 | $-38,549 | $25,767 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,213 | -74,899 | -51,597 | -26,780 | -21,974 |
| Capital Expenditure | -111 | -98 | N/A | -568 | -865 |
| Free Cash Flow | -58,324 | -74,997 | -51,597 | -27,348 | -22,839 |